Dr. Baik treats patients who have lung and head and neck cancers. She is also involved in clinical research of targeted therapies in lung cancer.
I believe the best cancer treatment decision stems from active collaboration with patients and their families, by understanding their values and priorities. I also believe in the importance of extending care to the community by better understanding cancer risk factors and developing prevention strategies for those at risk.
Lung, head and neck cancer. Clinical trials of targeted therapies and immunotherapy.
- Associate Professor, University of Washington School of Medicine
- Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center
- Medical Degree: University of Rochester School of Medicine. Rochester, NY
- Residency: Brown Medical School, Providence, RI
- Fellowship: Tufts Medical Center, Division of Hematology-Oncology, Boston, MA
- Master of Public Health: Harvard School of Public Health, Boston, MA
- Post-doctoral Research Fellowship: Fred Hutchinson Cancer Research Center
Dr. Christina Baik was very interested in sciences in high school. "But I also felt very drawn to community service. I felt that becoming a doctor was a perfect way to combine my interests in sciences and community service."
During residency, Dr. Baik took care of many patients with various illnesses and felt an especially close connection with cancer patients. "I felt that many cancer patients had a perspective of life that enriched and challenged me as a physician and as a person. I also felt very privileged as many cancer patients and their families allowed me to see some of the most intimate details of their lives as we took each step of the treatment process. While cancer diagnosis was devastating news for most patients and their families, I witnessed that the bad news brought out the best in many of them. So I decided that taking care of cancer patients would be a rewarding way to commit my time and energy."
Dr. Baik is involved in clinical research in which her focus is to develop effective targeted therapies in patients with lung cancer. She is also interested in understanding the reasons for the lack of effectiveness of immunotherapy in some patients. In her lifetime as a physician, Dr. Baik hopes metastatic lung cancer will become a manageable disease where patients can live long and productive lives even with cancer. She also hopes that the majority of the lung cancers will be detected at the early curable stages and that the cure rates of early stage disease will be significantly better than what it is at the present time.
Outside of work, Dr. Baik enjoys hiking and exploring the outdoors with her husband.